Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
Introduction: In recent decades, hemophilia A treatment has been focused on body weight, without taking pharmacokinetic parameters into account. Previous research has shown that the individual pharmacokinetic response is more effective in predicting the required dose of clotting factor. We want to e...
Main Authors: | Samuel sarmiento Doncel, Gina Alejandra Diaz Mosquera, Javier Mauricio Cortes, Nelson Ramirez, Francisco Javier Meza, Carol Agudelo Rico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Hematology Reports |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8904 |
Similar Items
-
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors
by: Samuel Sarmiento Doncel, et al.
Published: (2023-02-01) -
Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors
by: Samuel Sarmiento Doncel, et al.
Published: (2022-05-01) -
Acquired Hemophilia A with Gastrointestinal Bleeding
by: Narae Park, et al.
Published: (2020-01-01) -
Real pandemic world results of pharmacokinetic-tailored personalized prophylaxis of bleeds in Polish children and adolescents with severe hemophilia A
by: Tomasz Urasiński, et al.
Published: (2023-02-01) -
The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies
by: Kun Huang
Published: (2024-03-01)